Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?

A hypothesis that possible pleiotropic features of different statins could be explained by distinctions in their interaction with cell membrane is suggested. Molecular complexes of pravastatin and simvastatin with model of cell membrane were studied by method of nuclear magnetic resonance spectrosco...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Latfullin (Author), L. F. Galiullina (Author), I. Z. Rakhmatullin (Author), V. V. Klochkov (Author), A. V. Aganov (Author)
Format: Book
Published: Столичная издательская компания, 2015-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e3f704acce3d4c3d8590ec93d32e50b7
042 |a dc 
100 1 0 |a I. A. Latfullin  |e author 
700 1 0 |a L. F. Galiullina  |e author 
700 1 0 |a I. Z. Rakhmatullin  |e author 
700 1 0 |a V. V. Klochkov  |e author 
700 1 0 |a A. V. Aganov  |e author 
245 0 0 |a Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? 
260 |b Столичная издательская компания,   |c 2015-12-01T00:00:00Z. 
500 |a 1819-6446 
500 |a 2225-3653 
500 |a 10.20996/1819-6446-2015-11-6-634-637 
520 |a A hypothesis that possible pleiotropic features of different statins could be explained by distinctions in their interaction with cell membrane is suggested. Molecular complexes of pravastatin and simvastatin with model of cell membrane were studied by method of nuclear magnetic resonance spectroscopy. It was shown that pravastatin interacts almost exclusively with a surface of cell membrane and, therefore active transport system is needed to deliver pravastatin into the cell. In contrast, simvastatin is located in the inner part of model cell membrane. That's why it can passively penetrate into organism cells. Perhaps, these differences lead to distinctions of pleiotropic properties of these statins. 
546 |a EN 
546 |a RU 
690 |a statins 
690 |a pleiotropic effects 
690 |a nuclear magnetic resonance 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
655 7 |a article  |2 local 
786 0 |n Рациональная фармакотерапия в кардиологии, Vol 11, Iss 6, Pp 634-637 (2015) 
787 0 |n https://www.rpcardio.online/jour/article/view/444 
787 0 |n https://doaj.org/toc/1819-6446 
787 0 |n https://doaj.org/toc/2225-3653 
856 4 1 |u https://doaj.org/article/e3f704acce3d4c3d8590ec93d32e50b7  |z Connect to this object online.